Home LiteratureArticle Details
PMID: 14631078 Published · ppublish English Letter Comment

Re: Evaluation of acute candesartan cilexetil therapy in stroke survivors.

Stroke ·Vol. 34 ·No. 12 ·2003-12-00 ·Pages e237-8; author reply e237-8

Kernan WN

Abstract

暂无摘要

MeSH Terms
Benzimidazoles/adverse effects,therapeutic use Bias Biphenyl Compounds/adverse effects,therapeutic use Blood Pressure/drug effects Double-Blind Method Humans Randomized Controlled Trials as Topic/methods Research Design Stroke/drug therapy Survivors Tetrazoles
Chemicals
Benzimidazoles Biphenyl Compounds Tetrazoles candesartan cilexetil
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Kernan Walter N
Article Info
Journal
Stroke
Abbr.
Stroke
ISSN
1524-4628
DOI
10.1161/01.STR.0000104158.59498.BC
Published
2003-12-00
Pages
e237-8; author reply e237-8
Language
English
Region
United States
NLM ID
0235266
Subset
IM
Corrections
CommentOn
PMID: 12817109
External Links
PubMed source DOI: 10.1161/01.STR.0000104158.59498.BC View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2